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The aim of this study was to assess the endorsement of reporting guidelines in Korean traditional medicine (TM)
journals by reviewing their instructions to authors. We examined the instructions to authors in all of the TM journals
published in Korea to assess the appropriate use of reporting guidelines for research studies. The randomized
controlled trials (RCTs) published after 2010 in journals that endorsed reporting guidelines were obtained. The
reporting quality was assessed using the following guidelines: the 38-item Consolidated Standards of Reporting
Trials (CONSORT) statement for non-pharmacological trials (NPT); the 17-item Standards for Reporting Interventions
in Clinical Trials of Acupuncture (STRICTA) statement, instead of the 5-item CONSORT for acupuncture trials; and
the 22-item CONSORT extensions for herbal medicine trials. The overall item score was calculated and expressed
as a proportion.One journal that endorsed reporting guidelines was identified. Twenty-nine RCTs published in this
journal after 2010 met the selection criteria. General editorial policies such as those of the International Committee
of Medical Journal Editors (ICMJE) were endorsed by 15 journals. In each of the CONSORT-NPT articles, 21.6 to
56.8% of the items were reported, with an average of 11.3 items (29.7%) being reported. In the 24 RCTs (24/29,
82.8%) appraised using the STRICTA items, an average of 10.6 items (62.5%) were addressed, with a range of 41.2
to 100%. For the herbal intervention reporting, 17 items (77.27%) were reported. In the RCT studies before and after
the endorsement of CONSORT and STRICTA guidelines by each journal, all of the STRICTA items had significant
improvement, whereas the CONSORT-NPT items improved without statistical significance.The endorsement of
reporting guidelines is limited in the TM journals in Korea. Authors should adhere to the reporting guidelines,
and editorial departments should refer authors to the various reporting guidelines to improve the quality of
their articles.Introduction
In cases in which full reporting information is inaccess-
ible, billions of dollars are wasted, bias is introduced,
and research and the care of patients are detrimentally
affected [1]. Well-designed and well-conducted random-
ized controlled trials (RCTs) represent the best available
methodology for evaluating the effects of health care in-
terventions. In general, they deliver reliable results that
could inform future research or clinical practice. Poorly
executed trials with inadequate methodologies are asso-
ciated with bias and might produce exaggerated effects
of an intervention [2]. A thorough assessment of a trial's* Correspondence: drmslee@gmail.com
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unless otherwise stated.design, management and analysis is vital to assess the
quality and reliability of its published research. This type
of assessment is only possible if the trial report presents
the critical information required for such an appraisal.
High-quality reporting in evidence-based research arti-
cles is crucial for the dissemination and implementation
of research findings, and reporting guidelines are useful
tools for increasing the comprehensiveness, accuracy, and
transparency of research studies [3]. The lack of clear,
transparent, and sufficiently detailed reporting of RCTs is a
barrier to an adequate appraisal of the quality and applic-
ability of published trials [4].
In the mid-1990s, in response to concerns regarding the
quality of reporting in RCTs, an international group of
researchers, statisticians, epidemiologists and biomedicald. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Choi et al. Trials 2014, 15:429 Page 2 of 13
http://www.trialsjournal.com/content/15/1/429editors developed the Consolidated Standards of Report-
ing Trials (CONSORT) statement [5]. This statement
has been endorsed by the World Association of Medical
Editors, the International Committee of Medical Journal
Editors (ICMJE) and the Council of Science Editors [6].
The CONSORT statement is a comprehensive guideline
for reporting RCTs, and it is associated with trial design
and implementation improvements [7]. Since the develop-
ment of the CONSORT statement, several extensions and
elaborations have been included to include reporting re-
quirements for different types of trials and interventions
such as herbal interventions [8], non-pharmacological
treatments [9], reporting of harm [10], inferiority and
equivalence trials [11], pragmatic trials and Standards for
Reporting Interventions in Clinical Trials of Acupuncture
(STRICTA) [12].
Almost 600 general and specialty journals endorse the
CONSORT statement [13]. Although reporting guide-
lines play a central role in improving the quality of arti-
cles, there are considerable opportunities to improve the
reporting of Korean clinical trials. There has been a
considerable increase in the number of trials focused
on traditional medicine (TM) and complementary and
alternative medicine (CAM) in Korea [14]. The quality
of Korean clinical medical research articles has consist-
ently been a topic of discussion, and the guiding effect
of TM journals should not be ignored; therefore, it is ne-
cessary to review the requirements outlined by Korean
medical journals.
Considering these needs, several local studies assessing
the endorsement of reporting guidelines by journals and
authors are available [15-18]. Additionally, it is necessary
to assess the TM journals in Korea that endorse report-
ing guidelines to determine whether the articles pub-
lished in these journals provide satisfactory descriptions
of the study design and intervention by adopting stan-
dards for all of the items in the reporting guides.
In this study, we aimed to investigate the extent to
which Korean TM journals incorporated reporting
guidelines into their instructions for authors. Any refer-
ence to the ICMJE was studied, and the quality of the
reporting of RCTs in the TM journals that endorsed
reporting guidelines was assessed.Review
Methods
This study was reported in accordance with the guidelines
from PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) [19].Selection of journals and RCTs
We included the TM journals from our previous article,
which introduced all of the TM journals in a Koreanmedical database [20] and excluded those that did not
have a website.
The instructions for the authors in each TM journal
were downloaded, and the text referencing the CON-
SORT statement or other information relevant to the
reporting guidelines for trials was examined. Addition-
ally, we searched for any reference to the ICMJE’s
Uniform Requirement for Manuscripts Submitted to
Biomedical Journals. If the reporting guidelines were not
referenced in the journals, we assumed that the journal
had not adopted the reporting guidelines. We identified
the RCTs in the journals that had adopted reporting
guidelines by screening all of the issues. We retrieved
the parallel group of RCTs included in the journals pub-
lished after 2010 that had adopted reporting guidelines
and assessed whether the use of reporting guidelines in
the RCT reports was appropriate.
Data extraction
One author (JC) reviewed the websites of the TM jour-
nals. The instructions for authors, manuscript submis-
sion documents and relevant information for authors
were extracted as data sources, including guidelines or
instructions pertaining to the domains of editorial policy.
The data included the journal name, website, ISSN, gen-
eral policy references and reporting guidelines.
The screening of the title, abstract and full text of po-
tentially relevant RCTs was completed by two authors
(JC and JHJ). The full-text reports of the RCTs published
in journals that referred to reporting guidelines were
downloaded. Two authors (JC and JHJ) independently
reviewed these RCT reports to assess the quality of
reporting and to determine whether flow diagrams were
included and subsequently validated by the third re-
viewer (BKK). Disagreements were resolved by consen-
sus or by the third and fourth authors of this study
(KHK and MSL).
To ensure correct interpretation, the experienced sys-
tematic reviewers dedicated an extensive amount of
time to discussing all of the reporting statement guide-
lines and independently assessing and scoring the
reporting quality. The data were collected using a stan-
dardized form. To maximize accuracy, the data extrac-
tion was performed at least twice for each article during
several months. The approach and assumptions for de-
termining the study quality were discussed extensively
with the other authors. Disagreements were resolved by
discussion.
Identification of reporting guidelines
The CONSORT group highly recommended that guideline
users refer to the current version while writing or interpret-
ing the reports of clinical trials [13]. In this study, the
current version of the reporting guidelines was used to
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dorsed reporting guidelines. The extensions of the CON-
SORT statement were developed to provide additional
guidance for RCTs with specific designs, data and interven-
tions [13]. We attributed appropriate guideline tools for
each TM intervention in the RCTs. The extension of the
CONSORT statement for RCTs to non-pharmacological
trials (NPT) [9] was based on the CONSORT guidelines,
and for assessing an NPT the extension guidelines consider
specific issues that might affect the treatment results (that
is, surgery, technical interventions, rehabilitation, psycho-
therapy, behavioral interventions, implantable and non-
implantable devices, and complementary medicine).
We selected the reporting guidelines as follows: the NPT
extension of the CONSORT 2010 (38 items) [9], the CON-
SORT extension for herbal medicine RCTs (22 items) [8],
and the 17-item STRICTA guideline that was designed to
replace the 5 CONSORT items for acupuncture trials [12].
Data analysis
Each item was rated using a dichotomous scale (that is,
‘reported’ or ‘not reported’). The rating of ‘reported’ was
recorded in cases in which relevant information was at
least partially reported in the article. The rating of ‘not
reported’ was recorded when relevant information was
completely missing in the article.
The extracted variables included the publication and
reporting characteristics as well as the items rated as
‘reported’. The data were analyzed using Microsoft
2010 and SPSS WIN 12.0 K (SPSS, Inc., Chicago, IL,
USA). To assess the adherence to the CONSORT-NPT
guideline items, we calculated the number and propor-
tion of articles describing each item. The sum of the
scores was converted to a percentage value for the re-
ported items of each article (the proportion of each
item = the number of reported items/the total items)
and each section (the proportion of each section = the
percentage of the sum of items of each section/the total
items of each section). Additionally, before-and-after
comparisons were performed to investigate whether the
reporting quality of the RCTs was altered after the jour-
nal endorsed the reporting guidelines. We presented
the percentages and percentage differences with bi-
nominal 95% confidence intervals after the journal
adopted the CONSORT-NPT and STRICTA reporting
guidelines.
Results
Selection of the studies for analysis
The selection process is presented in Figure 1. We iden-
tified 47 TM journals as potential candidates for our in-
vestigation of the adoption of reporting guidelines for
clinical trials. Thirty-six journals were obtained from a
Korean medical database. Of these journals, one journalrecommends the use of reporting guidelines for clinical
trials. To investigate the implementation of the reporting
guidelines of the RCTs in this journal, the journal web-
site was manually searched for all of the articles pub-
lished from inception through December 2013.
After screening the abstracts and titles, we found 105
candidate articles. Subsequently, 76 articles were excluded
because they were published before 2010 (55 trials). We
additionally excluded the following: case studies (1), cross-
over studies (7), reviews (11) and articles for other reasons
(2). Lastly, 29 articles meeting our inclusion criteria were
included, read completely and evaluated.
A total of 29 articles were eligible for the study. The
types of interventions assessed in the 29 RCTs were as
follows: acupuncture (24 trials), herbal medicine (1 trial),
moxibustion (3 trials) and cupping (1 trial). The assess-
ments were classified as non-pharmacological (96.6%) or
pharmacological (3.4%).
General editorial policy
General editorial policies such as those of the ICMJE were
endorsed by 15 journals (15/36, 41.6%); however, the jour-
nals did not specifically refer to reporting guidelines in the
context of the ICMJE endorsement. Of the 15 journals, 2
journals specifically mentioned particular policies such as
the Helsinki Declaration on Ethical Principles for Medical
Research Involving Human Subjects, the Committee on
Publication Ethics (COPE), and the Institutional Animal
Ethical Committee (AEC) NIH Guide for the Care and
Use of Laboratory Animals (Table 1).
Endorsement of reporting guidelines in TM journals
One (Journal of Korean Acupuncture and Moxibustion
Medicine Society) of the 36 journals (1/36, 2.8%) re-
ferred to reporting guidelines in its instruction to
authors (Table 1). The website of this journal provided
the CONSORT guideline for reporting RCTs as well as
the Systematic Reviews of Diagnosis Research (STARD)
guideline, the STROBE guideline for observational stud-
ies, the Quality of Reporting of Meta-analyses (QUOROM)
guideline, the Meta-analyses of Observational Studies
(MOOSE) guideline and the Clinical Trial of Acupuncture
Intervention (STRICTA) guideline from 2013.
Assessment of the reporting quality of the included RCTs
CONSORT 2010 with non-pharmacological trials
A total of 28 RCT reports were collected from the Journal
of Korean Acupuncture & Moxibustion Medicine Society,
which endorsed a reporting guideline. The majority of
the 28 RCTs appraised using the 38-item guideline dem-
onstrated a very low reporting quality because they ad-
dressed an average of 11.3 CONSORT items (29.6%).
Among the 28 included articles, the reporting percentage
in each of the articles was 21.6 to 56.8% (Table 2).
Searched 13 medical databases to idenfy 
eligible TM Journals 
(n=47)
Journal included in qualitave synthesis
(n =1)
Finally RCTs assessed using reporng 
guideline (n =29)
TM Journals assessed for eligibility
(n=36)
Journals excluded (n=13) 
Reasons:
Not webpage (n = 8)
Not author guide (n=2)
Duplicated journal (n=1)
Journals excluded aer reading 
author guide (n = 35)




RCT but cross-over study (n=7)
Review (n=11)
Case study (n=1)
Not meet eligibility (n=2)























Full text RCT for further evaluaon in 
selected journal (n =105)
Acupuncture intervenon (n =24)
Others (n =5)
Figure 1 Flowchart of journal and articles through the phase screening and eligibility evaluation.
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‘randomization’ in the title, and 2 (7.1%) described the
experimental treatment, comparator, care providers, cen-
ters and blinding status. All of the articles (100%) de-
scribed the scientific background and objective. More
than 50% of the articles reported the participants (4a,
4b), the outcomes (6a) in the method section, the par-
ticipant flow (13a), the implementation of the interven-
tion (a new item in the CONSORT-NPT), the outcomes
and estimations (17a) in the results section and the limi-
tations (20) in the discussion section. The other items
were assessed in less than 50% of the RCTs. Four items
(7a, 7b, 12a and 12b) were not mentioned. The mean
percentages for each article section were as follows:
the title and abstract section, 8.93%; the introduction
section, 100%; the method section, 29.31%; the results
section, 40.26%; and the discussion section, 28.57%. The
mean percentage for other information was 15.48% and
for randomization, 9.82% (Table 3).
Of these RCT reports, 4 trials (14.3%) contained flow
diagrams, and 3 (10.7%) provided information regarding
the trial registration and protocol.STRICTA 2010 for acupuncture interventions trials
The majority of the 24 RCTs (24/29, 82.8%) appraised
using the 17 items scored more than 50% in reporting
quality by addressing an average of 10.6 STRICTA items
(62.5%). Using the STRICTA guidelines, the reporting
percentage for each of the articles was 41.18 to 100%,
and 2 articles (8.3%) reported all of the items (Table 2).
Among the 24 articles assessed using the 17 items on
the STRICTA 2010 guideline, 23 (95.8%) reported the style
of acupuncture and the name of the point used and pro-
vided a precise description of the control or comparator.
A total of 87.5% described the needle type, 79.2% reported
the reason for treatment and the needle retention time,
62.5% reported the depth of insertion, 58.3% reported a
description of the participating acupuncturists, and 54.2%
reported the number of treatment sessions.
The remainder of the items was reported in less than
50% of the RCTs. The mean reporting percentage was
62.5% for the acupuncture rational, 64.3% for the details
regarding the reasons for acupuncture being needed,
66.7% for the treatment regimen, and 68.8% for the con-
trol or comparator interventions (Table 4).
Table 1 The list of traditional medicine (TM) journals searched in reporting quality review





The Journal of Korean Oriental
Medicine (J Korean Orient Med)
1010-0695 http://www.jkom.org/ ICNJE nr
Korean Journal of Acupuncture
(Korean J Acupunct)
2287-3368 http://www.kjacupuncture.org/ ICNJE nr
Korean Journal of Oriental Physiology





The Korea Journal of Herbology
(Korean J Herbology)
1229-1765 http://www.herbology.or.kr/ ICNJE nr
Journal of Oriental Sports Medicine
(J Orien Sports Med)
N/A http://sskm.tistory.com/ nr nr
Journal of Korean Traditional
Oncology (J Korean Tradit Oncol)
1229-2621 http://www.koreanoncology.or.kr/ ICNJE nr
Journal of Pharmacopuncture
(Pharmacopuncture)
2093-6966 http://www.journal.ac/ nr nr
Journal of Acupuncture and Meridian
Studies (J Acupunct Meridian Stud)
2005-2901 http://journalams.com/00_Main.html ICNJE nr
The Korean Journal of Oriental





The Journal of Korean of Medical
GI-GONG Academy (J Korean GG)
N/A http://gigong.or.kr/index.php nr nr
The Korean Journal of Joongpoong
(Korean J Joongpoong)
1598-1843 http://www.kmstroke.or.kr/v2 nr nr
Journal of Korean Acupuncture
and Moxibustion Medicine Society
(J Korean Acupunct & Mox Med Sci)
1229-1137 http://www.acumoxa.or.kr/ nr CONSORT, STARD,
STROBE, QUOROM,
MOOSE, STRICTA
The Journal of Korean Oriental
Internal Medicine (J Korean Orient
Intern Med)
1226-9174 http://www.oim.or.kr nr nr
The Journal of Oriental Obstetrics and
Gynecology (J Orient Gynecol Obstet)
1229-4292 http://www.oobgy.or.kr/ nr nr
The Journal of Korean Oriental
Pediatrics (J Korean Orient Pediatr)
1226-8038 http://www.akop.or.kr/ ICNJE nr
Journal of Oriental Neuropsychiatry
(J Orient Neuropsychiatry)
1226-6396 http://www.onp.or.kr/ ICNJE nr
The Journal of Korean Oriental
Medical Ophthalmology and
Otolaryngology and Dermatology
(J Korean Orient Otolaryngol Dermatol)
1738-6640 http://ood.or.kr/ ICNJE nr
Journal of Oriental Medical
Thermology (J Orient Med Thermol)
1598-592X http://www.komt.or.kr/ nr nr
The Journal of The Korea Institute of
Oriental Medical Diagnostics
(J Korean Orient Med Diagn)
1226-5241 http://www.bmpomd.or.kr/ ICNJE
The Korean Journal of Oriental
Medical Prescription (Korean J
Orient Med Prescription)
1229-1218 http://www.ompak.okdanche.com/ nr nr
The Journal of Korean Medical
Classics (J Korean Med Classic)
1229-8328 http://www.wonjeon.org/ nr nr
The Journal of The Society of
HyungSang Medicine (J Sci
HyungSang Med)
1229-8328 http://www.hyungsang.or.kr/ nr nr
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Table 1 The list of traditional medicine (TM) journals searched in reporting quality review (Continued)
Journal of Sasang Constitutional
Medicine (J Sasang Constit Med)
1226-4075 http://www.esasang.com nr nr
Journal of Somun Oriental Medical
Society (J Somun Orient Med)
1975-2407 http://www.somun.or.kr nr nr
The Journal of Korea CHUNA Manual
Medicine for Spine and Nerves
(J Korea CHUNA Med Spine
& Nerves)
1598-1630 http://www.chuna.or.kr ICNJE
The Journal of Korean Medical History
(J Korean Med Hist)
1229-6147 http://www.medicalhistory.or.kr/ nr nr
Journal of Society of Korean Medicine
for Obesity Research (J Sci Korean
Med Obes Res)
1976-9334 http://www.obesity.or.kr/ ICNJE, Helsinki Declaration,
NIH Guide for the Care and
Use of Laboratory Animals
Journal of Oriental Rehabilitation
Medicine (J Orien Rehabil Med)
1229-1854 http://www.ormkorea.org/ ICNJE nr
Oriental Pharmacy and Experimental
Medicine (Orient Pharm Exp Med)
1598-2386 http://www.opem.org/ nr nr
Journal of East-West Nursing Research
(J East-West Nurses Res)




Journal of Ginseng Research
(J Ginseng Res)
1226-8453 http://www.ginsengsociety.org/eng/ ICMJE, COPE, Good Publication









0253-3073 http://www.ksp.or.kr/ nr nr
Korea Journal of Pharmacognosy 0253-3070 http://journal.ksp.or.kr/ nr nr
Korean Journal of Medicinal Crop
Science (Korean J Med Crop Sci)
0252-9777 http://www.medcrop.or.kr/ nr nr
International Journal of Genuine






AEC: Institutional Animal Ethical Committee; COPE: Committee on Publication Ethics; CONSORT: Consolidated Standards of Reporting Trials; ICMJE: International
Committee of Medical Journal Editors; MOOSE: Meta-analysis of Observational Studies in Epidemiology; nr: not reported; QUOROM: Quality of Reporting of
Meta-analyses; STARD: Standards for Reporting of Diagnostic Accuracy Studies; STROBE: Strengthening the Reporting of Observational Studies in Epidemiology;
STRICTA: Standards for Reporting Interventions in Clinical Trials of Acupuncture.
aReference to general editorial policies: whether the journals mentioned to general editorial policies.
bReporting guidance specific in introduction to authors: whether the ‘introduction to authors’ section of a journal provided any reporting guidance.
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One RCT was assessed using the recommendations for
the reporting of herbal interventions. Of the 22 items,
17 items (77.27%) were reported. Of the 6 intervention
items, the following 4 items (66.7%) were reported: the
product name, dosage regimen and quantitative descrip-
tion, placebo/control group and practitioner.
Comparison after journal adoption of reporting guidelines
Table 5 compares the reporting of the guideline items in
the RCTs from the journals that did or did not endorse
the CONSORT and STRICTA guidelines. The percent-
ages of the reported items in the RCTs (the percentagedifference, 21.1; 95% CI, 6.6 to 35.5) were better after
the adoption of the STRICTA reporting guidelines, with
statistical significance (P = 0.0042). In the CONSORT-
promoting journals, the completeness of the reporting
increased slightly (percentage difference, 3.1%; 95%
CI, -5.0 to 11.2) after endorsement of the guidelines by
the journal, without a statistically significant difference
(P = 0.4592) (Table 5).
Discussion
This study is the most comprehensive review of the
reporting guidelines in Korean TM journals. We utilized a
highly sensitive approach to the endorsement of reporting
Table 2 The reporting number and percentage for each item according to intervention in endorsing journal for
reporting guidelines
CONSORT-NPT STRICTA (Total number of items = 17)
Intervention Author (year) Nunber of
reported items
Percent (%) Number of
reported items
Percent (%)
Acupuncture (Total number of items = 37) Park (2010) [21] 11 29.7 12 70.6
Lee (2010) [22] 11 29.7 11 64.7
Kim (2010) [23] 9 24.3 10 58.8
Kwon (2010) [24] 8 21.6 11 64.7
Joung (2010) [25] 10 27.0 9 52.9
Yoon (2010) [26] 9 24.3 14 82.4
Kim (2010) [27] 10 27.0 17 100.0
Chung (2010) [28]a b 21 56.8 9 52.9
Choi (2010) [29] 10 27.0 10 58.8
Jang (2010) [30] 12 32.4 9 52.9
Kim (2011) [31]b 13 35.1 9 52.9
Park (2011) [32] 12 32.4 10 58.8
Park (2011) [33]a 11 29.7 9 52.9
Lee (2011) [34] 9 24.3 11 64.7
Jeong (2011) [35] 9 24.3 9 52.9
Shin (2011) [36] 10 27.0 7 41.2
Lee (2011) [37] 12 32.4 9 52.9
Im (2011) [38] 10 27.0 9 52.9
Kim (2011) [39] 10 27.0 11 64.7
Han (2011) [40] 11 29.7 13 76.5
Kim (2012) [41]a 19 51.4 10 58.5
Kim (2012) [42] 11 29.7 9 52.9
Kim (2013) [43] 11 29.7 10 58.8
Kim (2013) [44]a 19 51.4 17 100.0
Moxibustion (Total number of items = 38) Cho (2010) [45] 8 21.1
Lee (2012) [46] 9 23.7 - -
Kim (2013) [47]b 12 31.6 - -
Cupping (Total number of items = 38)
Kim (2013) [48] 9 23.7 - -
Herbal medicine (Total number of items = 22)
Song (2012) [49] 17 77.2 - -
CONSORT-NPT: Consolidated Standards of Reporting Trials with the non-pharmacological trials extension; STRICTA: Standards for Reporting Interventions in Clinical
Trials of Acupuncture.
Values are presented as number of reported items divided by the total number of items.
Intervention on CONSORT-NPT included acupuncture, moxibustion and cupping intervention article besides herbal medicine intervention.
aThis article included flow participant diagram.
bThis article included trial registration or protocol information.
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complete assessment of the reporting quality of the trials
published in journals that endorsed reporting guidelines.
In this study, 36 core journals were selected after investi-
gating the endorsement of reporting guidelines and the
uniform requirements for manuscripts (URM) of theseKorean TM journals. Our study has shown that most
Korean TM journals provide little or no guidance regard-
ing the information to report in describing research
dependent on study design and interventions. One journal
(the Journal of Acupuncture and Moxibustion Society) has
referenced the reporting guidelines in its instructions for
Table 3 The reporting number and percentage for each item of CONSORT 2010 checklist with the non-pharmacological
trials extension
Section/topic Descriptor summary








1.a) Identification as a randomized trial in the title 3 10.71
1.b) Structured summary of trial design, methods, results, and conclusions;
for specific guidance (In the abstract, description of the experimental
treatment, comparator, care providers, centers and blinding status.)
2 7.14
Total section (average) 2.5 8.93
Introduction
Background and objectives 2.a) Scientific background and explanation of rationale 28 100
2.b) Specific objectives or hypotheses 28 100
Total section (average) 28 100
Methods
Trial design 3.a) Description of trial design (for example, parallel, factorial) including
allocation ratio
4 13.79
3.b) Important changes to methods after trial commencement with reasons 0 0.00
Participants 4.a) Eligibility criteria for participants (When applicable, eligibility criteria for
centers and those performing the interventions.)
23 79.31
4.b) Settings and locations where the data were collected 23 79.31
Interventions 5) Precise details of both the experimental treatment and comparator - -
Outcomes 6.a) Completely defined pre-specified primary and secondary outcome
measures, including how and when they were assessed
17 58.62
6.b) Any changes to trial outcomes after the trial commenced with reasons 1 3.45
Sample size 7.a) How sample size was determined (When applicable, details of whether
and how the clustering by care providers or centers was addressed.)
0 0.00
7.b) When applicable, explanation of any interim analyses and stopping guidelines 0 0.00
Total section (average) 8.5 29.31
Randomization
Sequence generation 8.a) Method used to generate the random allocation sequence (When
applicable, how care providers were allocated to each trial group.)
8 28.57
8.b) Type of randomization; details of any restriction (for example, blocking and
block size.)
3 10.71
Allocation concealment 9) Mechanism used to implement the random allocation sequence (for
example, sequentially numbered containers), describing any steps taken to
conceal the sequence until interventions were assigned
1 3.57
Implementation 10) Who generated the random allocation sequence, who enrolled participants,
and who assigned participants to interventions
5 17.86
Blinding 11.a) If done, who was blinded after assignment to interventions (for example,
participants, care providers, those assessing outcomes) and how (Whether or
not those administering co-interventions were blinded to group assignment. If
blinded, method of blinding and description of the similarity of interventions.)
4 14.29
11.b) If relevant, description of the similarity of interventions 1 3.57
Statistical methods 12.a) Statistical methods used to compare groups for primary and secondary
outcomes (When applicable, details of whether and how the clustering by care
providers or centers was addressed.)
0 0.00
12.b) Methods for additional analyses, such as subgroup analyses and
adjusted analyses
0 0.00
Total section (average) 2.75 9.82
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Table 3 The reporting number and percentage for each item of CONSORT 2010 checklist with the non-pharmacological
trials extension (Continued)
Results
Participant flow (A diagram is
strongly recommended)
13.a) For each group, the numbers of participants who were randomly assigned,
received intended treatment, and were analyzed for the primary outcome (The
number of care providers or centers performing the intervention in each group
and the number of patients treated by each care provider or in each center.)
23 82.14
13.b) For each group, losses and exclusions after randomization, together
with reasons
5 17.86
Implementation of intervention Details of the experimental treatment and comparator as they were
implemented
25 89.29
Recruitment 14.a) Dates defining the periods of recruitment and follow-up 22 78.57
14.b) Why the trial ended or was stopped 1 3.57
Baseline data 15) A table showing baseline demographic and clinical characteristics for
each group (When applicable, descriptions of care providers (case volume,
qualification, expertise, and so on) and centers (volume) in each group.)
10 35.71
Numbers analyzed 16) For each group, number of participants (denominator) included in each
analysis and whether the analysis was by original assigned groups
3 10.71
Outcomes and estimation 17.a) For each primary and secondary outcome, results for each group, and
the estimated effect size and its precision (for example, 95% confidence interval)
27 96.43
17.b) For binary outcomes, presentation of both absolute and relative effect
sizes is recommended
1 3.57
Ancillary analyses 18) Results of any other analyses performed, including subgroup analyses
and adjusted analyses, distinguishing pre-specified from exploratory
1 3.57
Harms 19) All important harms or unintended effects in each group; for specific
guidance see CONSORT for harms
6 21.43
Total section (average) 11.3 40.26
Discussion
Limitations 20) Trial limitations, addressing sources of potential bias, imprecision, and,
if relevant, multiplicity of analyses
20 71.43
Generalizability 21) Generalizability (external validity) of the trial findings according to the
intervention, comparators, patients and care providers and centers involved
in the trial
2 7.14
Interpretation 22) Interpretation consistent with results, balancing benefits and harms, and
considering other relevant evidence (In addition, take into account the choice
of the comparator, lack of or partial blinding, unequal expertise of care
providers or centers in each group.)
2 7.14
Total section (average) 8 28.57
Other information
Registration 23) Registration number and name of trial registry 2 7.14
Protocol 24) Where the full trial protocol can be accessed, if available 2 7.14
Funding 25) Sources of funding and other support (for example, supply of drugs); role
of funders
9 32.14
Total section (average) 4.3 15.48
Total 11.28 29.6
CONSORT-NPT: Consolidated Standards of Reporting Trials with the non-pharmacological trials extension.
Values are presented as number of reported RCTs divided by the total number of eligible RCTs.
Intervention on non-pharmacological trials included moxibustion and cupping intervention article besides acupuncture and herbal medicine intervention.
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http://www.trialsjournal.com/content/15/1/429authors since 2013. Additionally, we found that the major-
ity of the articles failed to follow the reporting guidelines.
Fifteen journals mentioned the ICMJE or the URM.
An important aspect of RCT quality is related to the
consideration of randomization; however, in our study, allof the items are in very low percentages (9.82%). We hy-
pothesized that treatment in TM is a unique and complex
intervention, and difficulties in blinding and allocation
concealment are significantly influenced by the care pro-
viders’ expertise and the care center’s volume of treatment.
Table 4 The reporting number and percentage for each item of STRICTA 2010 checklist of information
Items Detail 24 acupuncture trials
Number of RCTs Percent (%)
1. Acupuncture rationale 1a) Style of acupuncture 23 95.8
1b) Reasoning for treatment provided, based on historical context, literature
sources, and/or consensus methods, with references where appropriate
19 79.2
1c) Extent to which treatment was varied 3 12.5
Total section (average) 15 62.5
2. Details of needling 2a) Number of needle insertions per subject per session (mean and range
where relevant)
11 45.8
2b) Names (or location if no standard name) of points used (uni/bilateral) 23 95.8
2c) Depth of insertion, based on a specified unit of measurement, or on a
particular tissue level
15 62.5
2d) Response sought 4 16.7
2e) Needle stimulation 15 62.5
2f) Needle retention time 19 79.2
2g) Needle type 21 87.5
Total section (average) 15.4 64.3
3. Treatment regimen 3a) Number of treatment sessions 13 54.2
3b) Frequency and duration of treatment sessions 19 79.2
Total section (average) 16 66.7
4. Other components of treatment 4a) Details of other interventions administered to the acupuncture group
(for example, moxibustion, cupping, herbs, exercises, lifestyle advice)
17 70.8
4b) Setting and context of treatment, including instructions to practitioners,
and information and explanations to patients
6 25.0
Total section (average) 11.5 47.9
5. Practitioner background 5) Description of participating acupuncturists (qualification or professional
affiliation, years in acupuncture practice, other relevant experience)
14 58.3
Total section (average) 14 58.3
6. Control or comparator interventions 6a) Rationale for the control or comparator in the context of the research
question, with sources that justify this choice
10 41.7
6b) Precise description of the control or comparator. If sham acupuncture
or any other type of acupuncture-like control is used, provide details as for
items 1 to 3 above.
23 95.8
Total section (average) 16.5 68.8
Total 10.6 62.5
STRICTA: Standards for Reporting Interventions in Clinical Trials of Acupuncture.
This checklist is designed to replace CONSORT 2010’s item 5 when reporting an acupuncture trial.
Values are presented as number of reported RCTs divided by the total number of eligible RCTs.
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http://www.trialsjournal.com/content/15/1/429A total of 4.3% of the studies referenced the trial registra-
tion number, protocol and funding source, which indicates
journal editors have not focused on these items.
The Journal of Korean Acupuncture and Moxibustion
Medicine Society is a core journal that is highly cited in
Korea. In this journal, we found that 29 parallel RCTs
of the 105 assessed RCTs did not report the number of
care providers and centers in each group. For non-
pharmacological treatments, the number of care providers
and centers in each group and the number of patients
treated by each care provider is essential so that the bio-
logical and statistical significance of the results could beassessed or the data reanalyzed. ‘Implementation of inter-
vention’ is a new item added to the CONSORT-NPT 2010
statement. Because participants and care providers are fre-
quently not blinded to treatment assignment in NPT, a
risk for unequal administration of additional treatments
and contamination might influence the estimates of the
treatment effect [9]. In our study, 25 RCTs (89.3%) pro-
vided details regarding the manner in which the interven-
tion was actually administered.
The CONSORT-NPT statement has not been trans-
lated into Korean; however, the STRICTA guidelines
have been translated into Korean and were published in
Table 5 Comparison of reported items in journals that did and did not promote adherence to CONSORT and STRICTA
statement
CONSORT-NPT STRICTA
Before 2013 After 2013 Before 2013 After 2013
Number of items reported/total number of items 282/912 51/150 228/391 27/34
Percent reported items in RCTs (n/N)a 30.9 34.0 58.3 79.4
Difference in percent between the two groups (CI)b 3.1 (-5.0 to 11.2) 21.1 (6.6 to 35.5)
P-value 0.4592 0.0042
CONSORT-NPT: Consolidated Standards of Reporting Trials with the non-pharmacological trials extension; STRICTA: Standards for Reporting Interventions in Clinical
Trials of Acupuncture; RCT: randomized controlled trials.
an/N: number of times reported/total number of items evaluated.
b95% confidence intervals (%).
P-value calculated for each of these before after comparisons.
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http://www.trialsjournal.com/content/15/1/429our endorsing journal in 2001 [50]. In addition, the
translation could be found on the revised STRICTA
website [51]. It is assumed that Korean journal editors
and authors have simple access to the STRICTA items
when reporting on acupuncture trials. Our findings
showed that the STRICTA items (10.6/17, 62.5%) are
more completely reported than the CONSORT-NPT
items (11.28/37, 29.6%).
To adequately translate research into practice, re-
search results should be reported by a method that is
useful to practicing clinicians and policymakers. Based
on evidence from systematic reviews, the implementa-
tion of reporting guidelines such as CONSORT for ran-
domized controlled trials might improve the quality of
research reporting. Other reporting guidelines similar to
the CONSORT statement provide advice on reporting
research methods and findings for other types of study
designs [52].
Several studies [53-55] have assessed the effect of
using the CONSORT statement to improve the reporting
of RCTs. These studies suggested that journal endorse-
ment of CONSORT might improve the completeness of
reporting in the RCTs they publish. In our study, we
found that RCTs published after reporting guidelines
were adopted by journals were more likely to include the
required reporting items shown in Table 5. Despite the
relative improvements when CONSORT is endorsed by
journals, the completeness of reporting remains subopti-
mal. In particular, Korean TM journals should guide
their authors towards reporting guidelines, which have
the potential to improve the quality of reporting and
consequently the quality of research.
This study identifies several specific tasks required to
improve the quality of clinical trials. First, all Korean
TM Journals should be more vigilant regarding the in-
formation in their instructions to authors and explicit in
their expectations of adherence to specific recommenda-
tions; additionally, they should cite the web address
for the guidelines they follow to ensure that the latest
versions and extensions are obtained. Second, in theinitial submission stage, TM authors should adhere to
the reporting guidance for the study design and inter-
vention. Third, several reporting guidelines exist, and
TM practitioners and researchers should consider the
other interventions and develop the formal endorse-
ment of guidelines for the TM intervention. Fourth,
improved education and awareness among all of the
stakeholders and hard-wired compliance through elec-
tronic journal submission systems could benefit the
quality of clinical trials.
This study has the following limitations. First, because
we found that only one Korean TM journal has adopted
reporting guidelines, we retrieved only 29 RCTs for assess-
ment, and the results could not fully represent all of the
Korean TM journals. We could hypothesize that journals,
RCTs or study designs not mentioned in this study have
little potential for better reporting. This hypothesis is likely
because many reporting guidelines have not been recom-
mended by Korean TM journals. Second, our measures of
study quality depend on the information reported in an
article, and no attempt was made to judge the clinical
merits or assumption models in the analyses. Third, no
telephone calls were made and no Emails were sent to the
editorial offices of the journals investigated; therefore, we
do not know the opinions of the journal editors regarding
the issues addressed in this study.
Our data suggest the need for TM journals to adopt
reporting guidelines because better reporting is likely to
influence the quality as well as the effect of future re-
search. Korean researchers could provide robust evidence
to establish health care standards for clinical practice. TM
researchers in Korea should exert significant effort in
improving the number and quality of primary studies by
considering the study design and unique treatment inter-
vention system in reference to reporting guidelines.
Conclusions
The endorsement of reporting guidelines is limited in
TM journals in Korea, and many items in research stud-
ies were far from satisfactory. We hope that all of the
Choi et al. Trials 2014, 15:429 Page 12 of 13
http://www.trialsjournal.com/content/15/1/429TM journals will support reporting guidelines by regis-
tering on the websites of the organizations that have
established reporting guideline statements. This article
should generate further research regarding the mechan-
ism for improving the quality of RCT reporting. Inter-
ested readers, reviewers, researchers, and editors in
Korea could use the reporting guide statements and gen-
erate theories for improving research.
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